Jeffrey Lipman
Researcher Next ID · RN-033469
Researcher · Biochemistry, Genetics and Molecular Biology
New York City Health and Hospitals Corporation
New York, Australia
- Works count
- 839
- Citation count
- 41,019
- H-index
- 101
- i10-index
- 485
Research interests
Publications
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study
Intensive Care Medicine · 2023 · https://doi.org/10.1007/s00134-022-06944-2
The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study
Clinical Infectious Diseases · 2020 · https://doi.org/10.1093/cid/ciaa224
Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit
Open Forum Infectious Diseases · 2018 · https://doi.org/10.1093/ofid/ofy313
Systemic Inflammatory Response Syndrome, Quick Sequential Organ Function Assessment, and Organ Dysfunction
CHEST Journal · 2016 · https://doi.org/10.1016/j.chest.2016.10.057
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
Intensive Care Medicine · 2016 · https://doi.org/10.1007/s00134-015-4188-0
Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis: A Meta-analysis of Individual Patient Data from Randomized Trials
American Journal of Respiratory and Critical Care Medicine · 2016 · https://doi.org/10.1164/rccm.201601-0024oc
An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care units
Journal of Antimicrobial Chemotherapy · 2014 · https://doi.org/10.1093/jac/dkt523
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
The Lancet Infectious Diseases · 2014 · https://doi.org/10.1016/s1473-3099(14)70036-2
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
The Lancet Respiratory Medicine · 2014 · https://doi.org/10.1016/s2213-2600(14)70061-x
The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents
Advanced Drug Delivery Reviews · 2014 · https://doi.org/10.1016/j.addr.2014.07.006
Augmented Renal Clearance in the ICU
Critical Care Medicine · 2013 · https://doi.org/10.1097/ccm.0000000000000029
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study
Intensive Care Medicine · 2012 · https://doi.org/10.1007/s00134-012-2695-9
The Clinical Relevance of Plasma Protein Binding Changes
Clinical Pharmacokinetics · 2012 · https://doi.org/10.1007/s40262-012-0018-5
Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1209759
Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
Clinical Infectious Diseases · 2012 · https://doi.org/10.1093/cid/cis856
Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients
CHEST Journal · 2011 · https://doi.org/10.1378/chest.11-1671
The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
Clinical Pharmacokinetics · 2010 · https://doi.org/10.2165/11539220-000000000-00000
Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
International Journal of Antimicrobial Agents · 2010 · https://doi.org/10.1016/j.ijantimicag.2010.06.008
Pharmacokinetic issues for antibiotics in the critically ill patient
Critical Care Medicine · 2009 · https://doi.org/10.1097/ccm.0b013e3181961bff
Augmented Renal Clearance
Clinical Pharmacokinetics · 2009 · https://doi.org/10.2165/11318140-000000000-00000
Principles of antibacterial dosing in continuous renal replacement therapy
Critical Care Medicine · 2009 · https://doi.org/10.1097/ccm.0b013e3181aab3d0
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Journal of Antimicrobial Chemotherapy · 2009 · https://doi.org/10.1093/jac/dkp139
A comparison of epinephrine and norepinephrine in critically ill patients
Intensive Care Medicine · 2008 · https://doi.org/10.1007/s00134-008-1219-0
Antibiotic resistance—What’s dosing got to do with it?
Critical Care Medicine · 2008 · https://doi.org/10.1097/ccm.0b013e318180fe62
Antibacterial Dosing in Intensive Care
Clinical Pharmacokinetics · 2006 · https://doi.org/10.2165/00003088-200645080-00001
Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units
Intensive Care Medicine · 2004 · https://doi.org/10.1007/s00134-004-2157-0
Current projects
No projects listed.